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the first comparison between GET and CBT, 123 received the study interventions. A further group of 40 of the 47 initially identified patients entered the BUC group (7 patients refused to participate). However, the final study sample comprised 50 patients (66% women) in the GET group, 52 patients (71% women) in the CBT group and 30 patients (77% women) in the BUC group, because cost-effectiveness data was available for a smaller group of patients than that initially considered. The mean age of the patients was 40 (+/-10.7) years in the GET group, ) years in the CBT group and 36.9 (+/-10.7) years in the BUC group,
Study design
This was a prospective study in which the patients were initially allocated to the two therapy options (GET versus CBT) in a randomised fashion. GET and CBT patients were then grouped (therapy group) and compared with BUC patients who were identified in a non-randomised fashion. The patients were recruited at 22 general practices in London and the South East of England. The length of follow-up was 8 months. The outcomes were assessed at baseline and 3 and 8 months. Details of the loss to follow-up were unclear.
Analysis of effectiveness
The analysis of the clinical study was restricted to patients whose cost-effectiveness data were available. The primary outcome measure used was the change in fatigue. This was assessed using a validated 11-item Likert instrument (for each item, 0 represented fatigue less than usual and 3 much more than usual), with higher scores representing higher levels of fatigue. The three groups of patients were comparable in terms of their demographics and the baseline values of the outcome measures. However, when GET and CBT patients were grouped, the therapy group had a higher proportion of non-white patients and significantly higher baseline fatigue, symptom and depression scores.
Effectiveness results
For GET versus CBT, the mean decrease in fatigue score for the GET group relative to the CBT group was 0.71 points, but this difference was not statistically significant. The data showed that 73% of GET patients and 79% of CBT patients had a decrease in fatigue of at least 4 points. The mean unit change was 2.4 (+/-2.2) in the GET group and 2.7 (+/-2.1) in the CBT group.
For therapy (GET or CBT) versus BUC, the outcomes were significantly better for therapy over BUC, with the mean difference being 4.38 points on the fatigue scale. In addition, only 60% of the BUC patients showed clinically significant improvements compared with 76% of the therapy group. The mean number of four-unit changes was 1.2 (+/-1.9) and 2.6 (+/-2.2), respectively.
Clinical conclusions
The effectiveness analysis showed that GET and CBT were equally effective, but therapy (either GET or CBT) was significantly more effective than BUC.
Measure of benefits used in the economic analysis
The summary benefit measure was the change in fatigue score, which was derived directly from the clinical analysis. The authors also considered two variations in this outcome measure for the economic evaluation. First, a variable that scored 1 if a clinically significant reduction in fatigue of at least 4 points was achieved. Second, a variable equal to the total change in the fatigue score divided by four to measure the units of change, with a 1-unit change being equal to four points on the original scale.
Direct costs
Discounting was not relevant since the costs were incurred during a short timeframe. The unit costs were not reported separately from the quantities of resources used, but the unit costs were provided for the majority of items. The health services included in the economic evaluation were GET, CBT, BUC, GPs, other clinicians, nurses, inpatient stays, physiotherapists (additional to those providing GET), counsellors, nutritionists, social services and complementary NHS Economic Evaluation Database (NHS EED) Produced by the Centre for Reviews and Dissemination
Copyright © 2013 University of York Page: 2 / 5 therapy, and informal care time spent in specific tasks. The specific tasks in the latter related to personal support, child care, help in or around the house, help outside the home, or other tasks.
The perspective adopted in the study might have been that of society since costs relevant to the health care service, as well as the economic impact of informal care, were included. Resource use was estimated using patient-level data collected alongside the effectiveness study. The data were gathered 3 months before baseline and at 8 months' followup. The costs came mainly from national figures. Other published sources were used for CBT and GET services, while the cost of informal care came from rates of home care workers. A fixed cost for the booklet used in the BUC group was used. The prices used referred to 2000/2001 figures.
Statistical analysis of costs
A multiple regression analysis was carried out to examine the statistical significance of differences in the estimated costs, so as to adjust for patient characteristics. Owing to the non-normal distribution of the costs, bootstrapping with 5,000 samples was used. Thus, confidence intervals (CIs) were generated.
Indirect Costs
The indirect costs were not considered in the economic evaluation.
Currency
UK pounds sterling ().
Sensitivity analysis
Sensitivity analyses were carried out to examine the robustness of the cost-effectiveness results to variations in some cost estimates. In particular, the analysis was re-run assuming that the cost of information care was equal to the national minimum wage or equal to zero. The cost of therapy was varied between one third higher and one third lower.
Estimated benefits used in the economic analysis
See the 'Effectiveness Results' section.
Cost results
For GET versus CBT (with sample differences controlled for), the total mean cost was 519 (90% CI: -814 -1,904; p=0.552) higher for the CBT than the GET group at baseline. However, at the follow-up assessment, it was 193 (90% CI: -946 -458; p=0.620) less for the CBT. The difference in total costs did not reach statistical significance.
For therapy versus BUC (with sample differences controlled for), the baseline costs for the therapy group were 385 (90% CI: -811 -1,702; p=0.664) greater than for the BUC group. At follow-up, the therapy group was 149 (90% CI: -708 -1,011; p=0.791) more expensive. Again, the difference in total costs did not reach statistical significance.
Synthesis of costs and benefits
The costs and benefits were combined using the net-benefit (NB) approach. Alternative values for the society's willingness to pay for an improvement in the benefit measure were used. These ranged from 0 to 10,000 at 500 increments. Cost-effectiveness acceptability curves were generated.
For GET versus CBT, if society placed a zero-value on a clinically significant decrease in fatigue, then the probability that CBT would be more cost-effective over GET was 0.589. This probability increased to 0.766 if society valued a clinically significant change at 5,000. At all values considered, CBT was more cost-effective. With a zero-value placed on a 4-point change in the Likert-scale, the probability that CBT would be more cost-effective was 0.663. For therapy versus BUC, therapy produced greater benefits at a non significantly higher cost. With a zero-value placed on decrease of fatigue, the probability that therapy was more cost-effective than BUC was 0.237. This probability was 0.818 when the value placed on fatigue was 4,500. If a 4-point change in the Likert-scale was valued at 500, then the probability that therapy is more cost-effective than BUC was 0.819.
The sensitivity analysis showed that the base-case results were quite robust. If the cost of informal care was 0, then the probability that therapy was cost-effective was 0.880, which became 0.894 with a unit cost of 4.10.
If the cost of therapy increased by one third, the probability that therapy was the most cost-effective option fell to 0.797 with a willingness to pay of 4,500. If the cost fell by one third, then the probability value was 0.836.
